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To the Editor,
In the 2017 winter issue of Acta Medica Croatica, 
we published a case report with review of literature 
entitled Diagnosing Macroamylasemia in Unexplai-
ned Hyperamylasemia. Th e paper discussed a case of 
a young female patient with elevated levels of amylase 
only in serum without related symptoms (1). Aft er ex-
cluding other causes, taking into consideration medi-
cal history, physical examination, and routine labora-
tory testing, we suspected and subsequently confi rmed 
macroamylasemia with a formula, the only method 
available to us at the time working in general practice 
(1). As mentioned in our article, macroamylasemia is 
a benign condition where macroamylase complexes 
form with immunoglobulins, which cannot be nor-
mally secreted by the kidneys, leading to falsely eleva-
ted serum levels, possibly creating confusion among 
unaware clinicians (1). Although the formula we used 
is an acceptable method to confi rm macroamylasemia, 
electrophoresis is considered a defi nite confi rmation, 
resulting in a smeared band instead of defi ned bands 
of amylase subtypes (salivary and pancreatic) (1). Th is 
test is not routinely used in Croatia, and unfortunately, 
we could not confi rm macroamylasemia in our patient 
with this test at the time (1).
Upon moving from general practice to hospital, 
we have become more aware of a routine test done for 
a similar but much more common condition, hyper-
prolactinemia. As prolactin commonly forms ma-
crohormone complexes, macroprolactin presence in 
hyperprolactinemia is routinely tested using polyet-
hylene glycol (PEG) precipitation. Th is test can also 
be used to confi rm macroamylasemia, stipulated in 
our original paper as well, alongside the formula and 
electrophoresis (1). With this test in mind having the 
opportunity to invite our original patient presenting 
herself, the patient voluntarily came in for the PEG 
precipitation test to further confi rm, or we could say, 
more defi nitely confi rm her condition of macroamyla-
semia. Th e test was performed using the method by 
Levitt and Ellis (2). PEG precipitable activity (PPA) 
was subsequently calculated with the formula %PPA = 
((activity blank x activity PEG)/activity blank) x 100, 
and a cut-off  value of 60% was used, according to Da-
vidson and Watson (2,3). Th e test result was positive 
for macroamylasemia, confi rming our previous suspi-
cion and calculation.
Considering our previous experience with macro-
enzymes, in particular our patient with macroamyla-
semia, and our further work with macroenzymes, a 
small study determining macroenzyme, that is, ma-
cro-aspartate (AST) and alanine transferase (ALT) 
prevalence in rheumatoid arthritis patients, and its 
eff ect on further diagnostics and treatment, of which 
preliminary results were presented at the 23rd IFCC/
EFLM European Congress of Clinical Chemistry and 
Laboratory Medicine in May 2019 (4), the concept 
of macroenzymes and their detection using the PEG 
precipitation test was presented to internists, that is, 
gastroenterologists, in our centre, which was positi-
vely received as some of the doctors noted following 
up patients with elevated serum amylase without an 
underlying cause. Since then, the test has been in-
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troduced into the repertoire of the laboratory, as it is 
simple and inexpensive, and already routinely done 
for the detection of macroprolactin, and gastroentero-
logists have been requesting the test for patients with 
unclear elevated serum amylase as a diff erential dia-
gnosis. Although it is unclear how the availability of 
the test will infl uence the management of patients with 
hyperamylasemia, if it will save resources and time by 
avoiding other diagnostics, it is hoped that, if nothing 
else, it will diagnose some patients with previously 
unexplained hyperamylasemia.
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